Do you have the same question? Follow this Question
Jun 11, 2026 - 09:01 AM
We’ve provided several answers to questions related to Cabometyx (Cabozantinib) , see some other helpful Q&A related to this product.
Question: Is this medication approved by any regulatory authorities?
Answer: Yes, it is licensed by the US FDA (Food and Drug Administration) and EMA (European Medicines Agency). FDA and EMA approval indicates that the drug has been rigorously evaluated for safety and effectiveness.
Question: What are the inactive ingredients in this medication?
Answer: The inactive ingredients include microcrystalline cellulose, lactose anhydrous, hydroxypropyl cellulose, croscarmellose sodium, colloidal silicon dioxide, and magnesium stearate. Inactive ingredients help with the stability, absorption, and manufacturing of the tablet, which ensures consistent dosing and effectiveness.
Question: What is the active ingredient in this medicine?
Answer: The active ingredient in this medicine is cabozantinib. Cabozantinib is a tyrosine kinase inhibitor, which means it works by blocking certain proteins involved in cancer cell growth. This is valuable for people seeking targeted cancer therapies.
